These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35104666)

  • 21. A novel long-range deletion spanning STX16 and NPEPL1 causing imprinting defects of the GNAS locus discovered in a patient with autosomal-dominant pseudohypoparathyroidism type 1B.
    Yang Y; Chu X; Nie M; Song A; Jiang Y; Li M; Xia W; Xing X; Wang O
    Endocrine; 2020 Jul; 69(1):212-219. PubMed ID: 32337648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.
    Bastepe M; Fröhlich LF; Hendy GN; Indridason OS; Josse RG; Koshiyama H; Körkkö J; Nakamoto JM; Rosenbloom AL; Slyper AH; Sugimoto T; Tsatsoulis A; Crawford JD; Jüppner H
    J Clin Invest; 2003 Oct; 112(8):1255-63. PubMed ID: 14561710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous Thrombosis in a Pseudohypoparathyroidism Patient with a Novel GNAS Frameshift Mutation and Complete Resolution of Vascular Calcifications with Acetazolamide Treatment.
    Seven Menevse T; Iwasaki Y; Yavas Abali Z; Gurpinar Tosun B; Helvacioglu D; Dogru Ö; Bugdayci O; Cyr SM; Güran T; Bereket A; Bastepe M; Turan S
    Horm Res Paediatr; 2024; 97(4):404-415. PubMed ID: 37906994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential Maternal Transmission of STX16-GNAS Mutations Responsible for Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B): Another Example of Transmission Ratio Distortion.
    Kiuchi Z; Reyes M; Jüppner H
    J Bone Miner Res; 2021 Apr; 36(4):696-703. PubMed ID: 33247854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mosaicism for GNAS methylation defects associated with pseudohypoparathyroidism type 1B arose in early post-zygotic phases.
    Elli FM; Bordogna P; Arosio M; Spada A; Mantovani G
    Clin Epigenetics; 2018; 10():16. PubMed ID: 29445425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted deletion of the Nesp55 DMR defines another Gnas imprinting control region and provides a mouse model of autosomal dominant PHP-Ib.
    Fröhlich LF; Mrakovcic M; Steinborn R; Chung UI; Bastepe M; Jüppner H
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9275-80. PubMed ID: 20427744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of aberrantly spliced transcripts of a novel de novo GNAS mutant in a male with albright hereditary osteodystrophy and PHP1A.
    Ham HJ; Baek KH; Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Moon SD
    Horm Metab Res; 2015 Jul; 47(8):585-90. PubMed ID: 25502941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia.
    Thiele S; Werner R; Ahrens W; Hübner A; Hinkel KG; Höppner W; Igl B; Hiort O
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):127-32. PubMed ID: 19658058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis.
    Chillambhi S; Turan S; Hwang DY; Chen HC; Jüppner H; Bastepe M
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3993-4002. PubMed ID: 20444925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A disruptive mutation in exon 3 of the GNAS gene with albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsalpha-L deficiency.
    Thiele S; Werner R; Ahrens W; Hoppe U; Marschke C; Staedt P; Hiort O
    J Clin Endocrinol Metab; 2007 May; 92(5):1764-8. PubMed ID: 17299070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications.
    Mazoni L; Apicella M; Saponaro F; Mantovani G; Elli FM; Borsari S; Pardi E; Piaggi P; Marcocci C; Cetani F
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3005-e3020. PubMed ID: 33780542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?
    Mantovani G; Elli FM; Spada A
    Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex Genomic Rearrangement Within the GNAS Region Associated With Familial Pseudohypoparathyroidism Type 1b.
    Nakamura A; Hamaguchi E; Horikawa R; Nishimura Y; Matsubara K; Sano S; Nagasaki K; Matsubara Y; Umezawa A; Tajima T; Ogata T; Kagami M; Okamura K; Fukami M
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2623-7. PubMed ID: 27253667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
    Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients.
    Han SR; Lee YA; Shin CH; Yang SW; Lim BC; Cho TJ; Ko JM
    Exp Clin Endocrinol Diabetes; 2021 Feb; 129(2):118-125. PubMed ID: 31546270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3.
    Elli FM; deSanctis L; Maffini MA; Bordogna P; Tessaris D; Pirelli A; Arosio M; Linglart A; Mantovani G
    Clin Epigenetics; 2019 Jan; 11(1):3. PubMed ID: 30616679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy.
    de Nanclares GP; Fernández-Rebollo E; Santin I; García-Cuartero B; Gaztambide S; Menéndez E; Morales MJ; Pombo M; Bilbao JR; Barros F; Zazo N; Ahrens W; Jüppner H; Hiort O; Castaño L; Bastepe M
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2370-3. PubMed ID: 17405843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercalcitoninaemia in pseudohypo-parathyroidism type 1A and type 1B.
    Yavropoulou MP; Chronopoulos E; Trovas G; Avramidis E; Elli FM; Mantovani G; Zebekakis P; Yovos JG
    Endocrinol Diabetes Metab Case Rep; 2019 Jan; 2019():. PubMed ID: 30703064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different pattern of epigenetic changes of the GNAS gene locus in patients with pseudohypoparathyroidism type Ic confirm the heterogeneity of underlying pathomechanisms in this subgroup of pseudohypoparathyroidism and the demand for a new classification of GNAS-related disorders.
    Brix B; Werner R; Staedt P; Struve D; Hiort O; Thiele S
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1564-70. PubMed ID: 24878042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput Molecular Analysis of Pseudohypoparathyroidism 1b Patients Reveals Novel Genetic and Epigenetic Defects.
    Danzig J; Li D; Jan de Beur S; Levine MA
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4603-e4620. PubMed ID: 34157100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.